Hua Xia Healthcare Holdings Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hua Xia Healthcare Holdings Limited with three other
companies in this sector in Hong Kong:
Hin Sang Group (International) Holding Co Ltd
sales of 188.55 million Hong Kong Dollars [US$24.02 million]
of which 96%
was Product Development Segment),
Extrawell Pharmaceutical Holdings Limited
(85.76 million Hong Kong Dollars [US$10.93 million]
Hong Kong Life Sciences and Technologies Group Ltd
(140.21 million Hong Kong Dollars [US$17.86 million]
of which 82%
was Trading Business).
Hua Xia Healthcare Holdings Limited reported sales of HK$330.46 million (US$42.10 million)
March of 2018.
increase of 22.6%
versus 2017, when the company's sales were HK$269.52 million.
Despite this increase, sales are still
below the level achieved in 2016, when Hua Xia Healthcare Holdings Limited
reported sales of HK$1.57 billion.